Growth Metrics

Gilead Sciences (GILD) Current Deferred Tax Assets (2016)

Gilead Sciences filings provide 8 years of Current Deferred Tax Assets readings, the most recent being $857.0 million for Q4 2016.

  • On a quarterly basis, Current Deferred Tax Assets rose 3.5% to $857.0 million in Q4 2016 year-over-year; TTM through Dec 2016 was $857.0 million, a 3.5% increase, with the full-year FY2016 number at $857.0 million, up 3.5% from a year prior.
  • Current Deferred Tax Assets hit $857.0 million in Q4 2016 for Gilead Sciences, up from $762.0 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $894.0 million in Q3 2015 to a low of $193.9 million in Q1 2012.
  • Median Current Deferred Tax Assets over the past 5 years was $385.6 million (2014), compared with a mean of $501.1 million.
  • Biggest five-year swings in Current Deferred Tax Assets: crashed 30.2% in 2012 and later soared 132.46% in 2015.
  • Gilead Sciences' Current Deferred Tax Assets stood at $262.6 million in 2012, then rose by 26.03% to $331.0 million in 2013, then soared by 53.47% to $508.0 million in 2014, then surged by 62.99% to $828.0 million in 2015, then rose by 3.5% to $857.0 million in 2016.
  • The last three reported values for Current Deferred Tax Assets were $857.0 million (Q4 2016), $762.0 million (Q3 2016), and $835.0 million (Q2 2016) per Business Quant data.